(Date:11/20/2009)...ORK, Nov. 20 Reportlinker.com anno...le in its catalogue. ,, Medical Adhesives and ...reportlinker.com/p0164242/Medical-Adhesives-and-Se...wire&utm_medium=pr&utm_campaign=prnewswire... is gaining preeminence in medical devices and equ...
(Date:11/20/2009)...H MEETING, Pa., Nov. 20 ...that questions why currently available medications...ing ignored, ECRI Institute, an independent nonpro...dence on Finasteride for Prevention of Prostate C... 2009, New York Times article, " Drugs to Deter ...
(Date:11/19/2009)...eland, Nov. 19 Warner Chilcott plc...ts previously announced secondary offering of 20,0...blic of $22.25 per share. The selling shareholder...ers, DLJ Merchant Banking, J.P. Morgan Partners (a..., L.P., certain other institutional investors and ...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Endologix Added to Russell Indexes 50394 1Endologix Added to Russell Indexes 50394 2Al Copeland Day Lives on Through Efforts To Cure Merkel Cell Carcinoma 50390 1Al Copeland Day Lives on Through Efforts To Cure Merkel Cell Carcinoma 50390 2Al Copeland Day Lives on Through Efforts To Cure Merkel Cell Carcinoma 50390 3Connectyx Technologies Holdings Groups CEO Gives Shareholders a Summary of Events for First Half of 2009 and Announces Teleconference Call on July 9th 50387 1Connectyx Technologies Holdings Groups CEO Gives Shareholders a Summary of Events for First Half of 2009 and Announces Teleconference Call on July 9th 50387 2Connectyx Technologies Holdings Groups CEO Gives Shareholders a Summary of Events for First Half of 2009 and Announces Teleconference Call on July 9th 50387 3...,Alzheimer,s Foundation of America (AFA) today cal...enings, especially in light of research,indicating...recognized,often enough and that early diagnosis c...e interventions. Eric J. Hall, AFA,s chief execut...nior research scientist at the Stanford/VA Aging C...
...of Connective Tissue Oncology, Society held in S...and tolerability of perifosine as a single age...sensitive sarcomas, NEW YORK, Nov. 5 Keryx Bioph...d that preliminary data demonstrating the,tolerabi...) in patients,with refractory, rare sarcomas was p...
Other Medicine Technology:Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6(Date:11/22/2009)...Nov. 21 Congressman Cha...on the United States Senate,s vote tonight to proc...n: ,, "Senators Arlen Specter and Bob Casey des...anians for casting stand-up, critical votes in the...ic Affordable Health Care Reform legislation to fu...
(Date:11/21/2009)...N, Nov. 21 A regional i...cerciasis (river blindness) in the Americas has su...in recent years, as evidenced by a 31% decrease in...inistration in six endemic countries. Results wer... American Society of Tropical Medicine and Hygiene...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game,...od Touch. , Mountain View...st popular and addictive game, SplitWords, is now ...s is designed to help banish that ,tip of the tong...brain game challenges the brain by encouraging us...
(Date:11/20/2009)... NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Phar...eeting of Shareholders will be held on Monday, Dec...onsider approval of two special resolutions. The f...e the sale of all or substantially all of the asse... for in the asset purchase agreement dated Novembe...
(Date:11/20/2009)... N.J., Nov. 20 Rates of ...e peaked in late October, but the pandemic flu vir...n all age groups, including the elderly, according... (NYSE: DGX ), the world,s leading provider of d..., In its most recent Quest Diagnostics Health Tren...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3... Knowing what someone eats can help doctors predi...tely, according to a new study by scientists in Gr...dietary factors in cardiovascular disease (CVD) ri...the models yield. The study, "Inclusion of Dietar...
...s Meet Strict Quality and Safety Standards , , MI...ion (CCA), the retail clinic industry,s member-bas...irectors that its member clinics are certified and...ds in March of 2007 with input from national medic...
...niversity of Liverpool will launch a new national ...ctions such as HIV and tuberculosis. , The Centre...irman of the Health Protection Agency, is one of 1...ture has received 13.5 million funding from NIHR a...
...mers can ask their pharmacists , , OMAHA, Neb., ...be smart with their money. When it comes to healt...riptions written by physicians to less expensive s...hysicians. This switch can have unwanted effects f...
...., Feb. 10 The Clean Tech Open, the non-,profit t...work, and funding to,make clean tech possible and ...n season today. At its first monthly Breakfast Bri...was keynoted by Kevin,Chen, who directs Green Ener...
...m up to Drive Performance Improvements World Wide ...ion ( www.activplant.com ) announced today that Gl...ork agreement naming Activplant as a recommended b...ed the ease of use that empowers operators, engine...
Other Medicine News:Health News:In Month of the Heart, Scientists Identify Better Way to Predict Heart-Disease Risk 2Health News:Convenient Care Association, Jefferson Medical College Certify Member Convenient Care Clinics 2Health News:Convenient Care Association, Jefferson Medical College Certify Member Convenient Care Clinics 3Health News:Convenient Care Association, Jefferson Medical College Certify Member Convenient Care Clinics 4Health News:Biomedical research center opens in Liverpool 2Health News:Patients Urged to be Aware of Prescription Switching 2Health News:Clean Tech Open Announces $125M+ Raised for Clean Tech Startups; Takes 2009 Competition National 2Health News:Clean Tech Open Announces $125M+ Raised for Clean Tech Startups; Takes 2009 Competition National 3Health News:Activplant Corporation Announces Global Agreement with GlaxoSmithKline 2Hartman Mosquito Forceps
Halstead Curved Haemostatic Mosquito Forceps - Non-Magnetic
Wills Hospital Utility Forceps
McCullough Utility Forceps
Medicine Products: